127 related articles for article (PubMed ID: 9786226)
21. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
22. Elevated maternal serum alpha-fetoprotein levels and maternal risk factors. Their association with pregnancy complications.
Capeless EL; Kelleher PC; Walters CP
J Reprod Med; 1992 Mar; 37(3):257-60. PubMed ID: 1373447
[TBL] [Abstract][Full Text] [Related]
23. Maternal serum α-fetoprotein at 11-13 weeks' gestation in spontaneous early preterm delivery.
Beta J; Bredaki FE; Rodriguez Calvo J; Akolekar R; Nicolaides KH
Fetal Diagn Ther; 2011; 30(2):88-93. PubMed ID: 21411977
[TBL] [Abstract][Full Text] [Related]
24. Placental sonolucency and pregnancy outcome in women with elevated second trimester serum alpha-fetoprotein levels.
Kuo PL; Lin CC; Lin YH; Guo HR
J Formos Med Assoc; 2003 May; 102(5):319-25. PubMed ID: 12874670
[TBL] [Abstract][Full Text] [Related]
25. Estrogen and alpha-fetoprotein levels in maternal and umbilical cord blood samples in relation to birth weight.
Nagata C; Iwasa S; Shiraki M; Shimizu H
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1469-72. PubMed ID: 16896034
[TBL] [Abstract][Full Text] [Related]
26. Radioimmunoassay of maternal serum -fetoprotein associated with pregnancy.
Ishiguro T; Nishimura T
Am J Obstet Gynecol; 1973 May; 116(1):27-33. PubMed ID: 4121367
[TBL] [Abstract][Full Text] [Related]
27. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
28. Autism spectrum disorders and maternal serum α-fetoprotein levels during pregnancy.
Abdallah MW; Grove J; Hougaard DM; Nørgaard-Pedersen B; Ibrahimov F; Mortensen EL
Can J Psychiatry; 2011 Dec; 56(12):727-34. PubMed ID: 22152641
[TBL] [Abstract][Full Text] [Related]
29. The relation between multiple births and maternal risk of breast cancer.
Nasca PC; Weinstein A; Baptiste M; Mahoney M
Am J Epidemiol; 1992 Dec; 136(11):1316-20. PubMed ID: 1488959
[TBL] [Abstract][Full Text] [Related]
30. Maternal characteristics and mid-pregnancy serum biomarkers as risk factors for subtypes of preterm birth.
Jelliffe-Pawlowski LL; Baer RJ; Blumenfeld YJ; Ryckman KK; O'Brodovich HM; Gould JB; Druzin ML; El-Sayed YY; Lyell DJ; Stevenson DK; Shaw GM; Currier RJ
BJOG; 2015 Oct; 122(11):1484-93. PubMed ID: 26111589
[TBL] [Abstract][Full Text] [Related]
31. [The value of maternal first and second trimester serum data of β-hCG, PAPP-A, AFP and uE3 in the prediction of preeclampsia].
Gu W; Lin J; Hou Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):101-7. PubMed ID: 25877605
[TBL] [Abstract][Full Text] [Related]
32. Outcome of pregnancy in relation to maternal serum alpha-fetoprotein levels in the second trimester. An evaluation of a screening program and a longitudinal follow-up.
Bremme K; Eneroth P; Nilsson B; Marsk L; Hagenfeldt L
Gynecol Obstet Invest; 1988; 26(3):191-205. PubMed ID: 2467849
[TBL] [Abstract][Full Text] [Related]
33. Maternal serum transformed alpha-fetoprotein levels in women with intrauterine growth retardation.
Bartha JL; Illanes S; González-Bugatto F; Abdel-Fattah SA; Mizejewski GJ; Soothill PW
Fetal Diagn Ther; 2007; 22(4):294-8. PubMed ID: 17361083
[TBL] [Abstract][Full Text] [Related]
34. Third Trimester Estrogens and Maternal Breast Cancer: Prospective Evidence.
Cohn BA; Cirillo PM; Hopper BR; Siiteri PK
J Clin Endocrinol Metab; 2017 Oct; 102(10):3739-3748. PubMed ID: 28973345
[TBL] [Abstract][Full Text] [Related]
35. Maternal serum alpha-fetoprotein levels are normal in Fanconi anemia: Can it be a lack of postnatal inhibition of AFP gene resulting in the elevation?
Aslan D; Karabacak RO; Aslan OD
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27805304
[TBL] [Abstract][Full Text] [Related]
36. 2nd-trimester maternal serum human chorionic gonadotropin and alpha-fetoprotein levels in male and female fetuses with Down syndrome.
Lehavi O; Aizenstein O; Evans MI; Yaron Y
Fetal Diagn Ther; 2005; 20(3):235-8. PubMed ID: 15824504
[TBL] [Abstract][Full Text] [Related]
37. [Determination of maternal serum alpha fetoprotein with a Polish AFP radioimmunoassay--a suitable screening method for neural tube defects?].
Schlosser H; Greiff R
Zentralbl Gynakol; 1986; 108(15):914-8. PubMed ID: 2429479
[TBL] [Abstract][Full Text] [Related]
38. First-trimester screening for neural tube defects using alpha-fetoprotein.
Bredaki FE; Poon LC; Birdir C; Escalante D; Nicolaides KH
Fetal Diagn Ther; 2012; 31(2):109-14. PubMed ID: 22377693
[TBL] [Abstract][Full Text] [Related]
39. Pregnancy outcomes regarding maternal serum AFP value in second trimester screening.
Bartkute K; Balsyte D; Wisser J; Kurmanavicius J
J Perinat Med; 2017 Oct; 45(7):817-820. PubMed ID: 27771626
[TBL] [Abstract][Full Text] [Related]
40. Birth weight, breast cancer and the potential mediating hormonal environment.
Bukowski R; Chlebowski RT; Thune I; Furberg AS; Hankins GD; Malone FD; D'Alton ME
PLoS One; 2012; 7(7):e40199. PubMed ID: 22815728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
